Literature DB >> 20926752

Incidence and contributors to potential drug-drug interactions in hospitalized patients.

Leanne Reimche1, Alan J Forster, Carl van Walraven.   

Abstract

Drug-drug interactions (DDIs) are drug combinations that result in pharmacological or clinical responses that differ from solitary administration. Previous studies of DDIs have been limited to particular drugs or particular patient populations. The authors performed a retrospective cohort study of all adults admitted to a teaching hospital between 1999 and 2005. All medications administered to patients were identified and compared with a standard reference of important DDIs. The authors measured the potential DDI incidence density as the percentage of time in the hospital during which patients were exposed to at least 1 DDI and used multivariate Poisson regression to determine its determinants. A total of 19.3% of 140 349 hospitalizations had at least 1 potential DDI. The potential DDI incidence density was 18.8%. Factors having the greatest influence on potential DDI incidence density included increased patient age (adjusted rate ratio patient >75 years vs <30 years, 2.25; 95% CI, 2.15-2.35), increased number of drug orders (adjusted rate ratio, 2.27 [2.23-2.30] for logarithm), and patient service (adjusted rate ratio, 1.49 [1.46-1.52] for surgical vs medical service). Potential DDIs were present during one fifth of hospitalization time.

Entities:  

Mesh:

Year:  2010        PMID: 20926752     DOI: 10.1177/0091270010378858

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  20 in total

1.  Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.

Authors:  M Ángeles Fernández de Palencia Espinosa; M Sacramento Díaz Carrasco; José Luis Alonso Romero; Amelia de la Rubia Nieto; Alberto Espuny Miró
Journal:  Int J Clin Pharm       Date:  2015-09-21

2.  Evaluation of Potential Drug-Drug Interactions with Antidepressants in Two Tertiary Care Hospitals.

Authors:  Muhammad Salman Rafi; Syed Baqir Shyum Naqvi; Muhammad Umair Khan; Muhammad Fayyaz; Nida Ashraf; Maqsood Ahmed Khan; Akram Ahmad; Sameer Dhingra
Journal:  J Clin Diagn Res       Date:  2015-07-01

3.  Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.

Authors:  Maria A P Martins; Daniel D Ribeiro; Vandack A Nobre; Fabiana R Pereira; Cibele C César; Manoel O C Rocha; Antonio L P Ribeiro
Journal:  Eur J Clin Pharmacol       Date:  2012-09-28       Impact factor: 2.953

4.  Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.

Authors:  Julia Amkreutz; Alexander Koch; Lukas Buendgens; Anja Muehlfeld; Christian Trautwein; Albrecht Eisert
Journal:  Int J Clin Pharm       Date:  2017-08-19

5.  Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic.

Authors:  Petra Langerová; Michal Prokeš; Martin Konvalinka; Jana Fürstová; Karel Urbánek
Journal:  Eur J Pediatr       Date:  2013-01-19       Impact factor: 3.183

6.  Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.

Authors:  M Angeles Fernández de Palencia Espinosa; M Sacramento Díaz Carrasco; José Luis Fuster Soler; Guadalupe Ruíz Merino; M Amelia De la Rubia Nieto; Alberto Espuny Miró
Journal:  Int J Clin Pharm       Date:  2014-09-10

Review 7.  Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.

Authors:  Wu Yi Zheng; L C Richardson; L Li; R O Day; J I Westbrook; M T Baysari
Journal:  Eur J Clin Pharmacol       Date:  2017-10-23       Impact factor: 2.953

8.  Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis.

Authors:  Nadine Shehata; Alan J Forster; Nadine Lawrence; Robin Ducharme; Dean A Fergusson; Michaël Chassé; Deanna M Rothwell; Paul C Hébert; Alan T Tinmouth; Kumanan Wilson
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

9.  Incidence of Potential Drug-Drug Interaction and Related Factors in Hospitalized Neurological Patients in two Iranian Teaching Hospitals.

Authors:  Soha Namazi; Shiva Pourhatami; Afshin Borhani-Haghighi; Sareh Roosta
Journal:  Iran J Med Sci       Date:  2014-11

10.  A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal.

Authors:  Sushmita Sharma; Himal Paudel Chhetri; Kadir Alam
Journal:  Indian J Pharmacol       Date:  2014 Mar-Apr       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.